Sellas CEO Stergiou backs ‘rigorous, unblinded’ REGAL AML data
Sellas CEO Stergiou said rigorous, unblinded data from its pivotal AML trial will speak for itself as the REGAL catalyst nears.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.